{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T14:34:23Z","timestamp":1781793263823,"version":"3.54.5"},"reference-count":100,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,4]],"date-time":"2022-11-04T00:00:00Z","timestamp":1667520000000},"content-version":"vor","delay-in-days":1464,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1111\/jth.14276","type":"journal-article","created":{"date-parts":[[2018,8,30]],"date-time":"2018-08-30T01:00:58Z","timestamp":1535590858000},"page":"2133-2146","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["Antithrombotic therapy management of adult and pediatric cardiac surgery patients"],"prefix":"10.1016","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1171-0548","authenticated-orcid":false,"given":"L.","family":"Baumann Kreuziger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Karkouti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Tweddell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.P.","family":"Massicotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1111\/jth.14276_bb0010","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1161\/CIR.0000000000000558","article-title":"Heart disease and stroke statistics\u20102018 update: a report from the American Heart Association","volume":"137","author":"Benjamin","year":"2018","journal-title":"Circulation"},{"key":"10.1111\/jth.14276_bb0015","unstructured":"Lafortune G, Balestat G, Durand A. Comparing activities and performance of the hospital sector in Europe. Organisation for Economic Co\u2010operation and Development, 2012."},{"key":"10.1111\/jth.14276_bb0020","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1001\/jama.2013.282437","article-title":"Trends in aortic valve replacement for elderly patients in the United States, 1999\u20102011","volume":"310","author":"Barreto\u2010Filho","year":"2013","journal-title":"JAMA"},{"key":"10.1111\/jth.14276_bb0025","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1161\/CIRCULATIONAHA.115.019307","article-title":"Congenital heart defects in the United States: estimating the magnitude of the affected population in 2010","volume":"134","author":"Gilboa","year":"2016","journal-title":"Circulation"},{"key":"10.1111\/jth.14276_bb0030","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.healun.2017.07.005","article-title":"Eighth annual INTERMACS report: special focus on framing the impact of adverse events","volume":"36","author":"Kirklin","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"10.1111\/jth.14276_bb0035","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.healun.2017.06.017","article-title":"Second annual Pediatric Interagency Registry for Mechanical Circulatory Support (Pedimacs) report: pre\u2010implant characteristics and outcomes","volume":"37","author":"Blume","year":"2018","journal-title":"J Heart Lung Transplant"},{"key":"10.1111\/jth.14276_bb0040","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1053\/j.jvca.2008.08.007","article-title":"The inflammatory response to cardiopulmonary bypass: part 1\u2013mechanisms of pathogenesis","volume":"23","author":"Warren","year":"2009","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1111\/jth.14276_bb0045","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJM198102263040901","article-title":"Complement activation during cardiopulmonary bypass: evidence for generation of C3a and C5a anaphylatoxins","volume":"304","author":"Chenoweth","year":"1981","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.14276_bb0050","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1053\/j.jvca.2015.08.001","article-title":"Platelet microvesicles (Microparticles) in cardiac surgery","volume":"30","author":"Tempo","year":"2016","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1111\/jth.14276_bb0055","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1182\/blood-2015-05-648030","article-title":"Free hemoglobin increases von Willebrand factor\u2010mediated platelet adhesion in vitro: implications for circulatory devices","volume":"126","author":"Da","year":"2015","journal-title":"Blood"},{"key":"10.1111\/jth.14276_bb0060","doi-asserted-by":"crossref","first-page":"S715","DOI":"10.1016\/S0003-4975(02)04701-X","article-title":"Inflammatory response to cardiopulmonary bypass","volume":"75","author":"Levy","year":"2003","journal-title":"Ann Thorac Surg"},{"key":"10.1111\/jth.14276_bb0065","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.thromres.2003.11.006","article-title":"Secretion of tissue plasminogen activator and plasminogen activator inhibitor 1 during cardiopulmonary bypass","volume":"112","author":"Chandler","year":"2003","journal-title":"Thromb Res"},{"key":"10.1111\/jth.14276_bb0070","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/S0003-4975(03)01520-0","article-title":"Cardiopulmonary bypass in man: role of the intestine in a self\u2010limiting inflammatory response with demonstrable bacterial translocation","volume":"77","author":"Rossi","year":"2004","journal-title":"Ann Thorac Surg"},{"key":"10.1111\/jth.14276_bb0075","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.bpa.2015.03.006","article-title":"Cardiopulmonary bypass in the pediatric population","volume":"29","author":"Whiting","year":"2015","journal-title":"Best Pract Res Clin Anaesthesiol"},{"key":"10.1111\/jth.14276_bb0080","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1051\/ject\/201042009","article-title":"Management and monitoring of anticoagulation for children undergoing cardiopulmonary bypass in cardiac surgery","volume":"42","author":"Gruenwald","year":"2010","journal-title":"J Extra Corpor Technol"},{"key":"10.1111\/jth.14276_bb0085","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1182\/blood-2015-06-651539","article-title":"Improving evidence on anticoagulant therapies for venous thromboembolism in children: key challenges and opportunities","volume":"126","author":"Goldenberg","year":"2015","journal-title":"Blood"},{"key":"10.1111\/jth.14276_bb0090","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1538-7836.2011.04584.x","article-title":"Developmental hemostasis: recommendations for laboratories reporting pediatric samples","volume":"10","author":"Ignjatovic","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14276_bb0095","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ppedcard.2017.08.006","article-title":"Developmental hemostasis and ventricular assist devices: a troubled relationship","volume":"47","author":"Massicotte","year":"2017","journal-title":"Prog Pediatr Cardiol"},{"key":"10.1111\/jth.14276_bb0100","doi-asserted-by":"crossref","first-page":"2S","DOI":"10.1016\/0002-9343(89)80523-6","article-title":"Biochemistry of heparin antithrombin interactions, and the physiologic role of this natural anticoagulant mechanism","volume":"87","author":"Rosenberg","year":"1989","journal-title":"Am J Med"},{"key":"10.1111\/jth.14276_bb0105","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/0003-4975(92)90451-9","article-title":"Coagulation defects in neonates during cardiopulmonary bypass","volume":"54","author":"Kern","year":"1992","journal-title":"Ann Thorac Surg"},{"key":"10.1111\/jth.14276_bb0110","doi-asserted-by":"crossref","first-page":"e326S","DOI":"10.1378\/chest.11-2298","article-title":"Perioperative management of antithrombotic therapy: antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence\u2010Based Clinical Practice Guidelines","volume":"141","author":"Douketis","year":"2012","journal-title":"Chest"},{"key":"10.1111\/jth.14276_bb0115","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.jacc.2016.11.024","article-title":"2017 ACC expert consensus decision pathway for periprocedural management of anticoagulation in patients with nonvalvular atrial fibrillation: a report of the American College of Cardiology Clinical Expert Consensus Document Task Force","volume":"69","author":"Doherty","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/jth.14276_bb0120","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1093\/eurheartj\/ehs253","article-title":"2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association","volume":"33","author":"Camm","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1111\/jth.14276_bb0125","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1056\/NEJMoa1501035","article-title":"Perioperative bridging anticoagulation in patients with atrial fibrillation","volume":"373","author":"Douketis","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.14276_bb0130","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1001\/jamainternmed.2015.1843","article-title":"Bleeding, recurrent venous thromboembolism, and mortality risks during warfarin interruption for invasive procedures","volume":"175","author":"Clark","year":"2015","journal-title":"JAMA Intern Med"},{"key":"10.1111\/jth.14276_bb0135","doi-asserted-by":"crossref","first-page":"e1159","DOI":"10.1161\/CIR.0000000000000503","article-title":"2017 AHA\/ACC focused update of the 2014 AHA\/ACC guideline for the management of patients with valvular heart disease: a Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"135","author":"Nishimura","year":"2017","journal-title":"Circulation"},{"key":"10.1111\/jth.14276_bb0140","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1016\/S0140-6736(14)61685-8","article-title":"Four\u2010factor prothrombin complex concentrate versus plasma for rapid vitamin K antagonist reversal in patients needing urgent surgical or invasive interventions: a phase 3b, open\u2010label, non\u2010inferiority, randomised trial","volume":"385","author":"Goldstein","year":"2015","journal-title":"Lancet"},{"key":"10.1111\/jth.14276_bb0145","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/MAT.0000000000000259","article-title":"Safety of prothombin complex concentrate to control excess bleeding during continuous flow LVAD insertion","volume":"61","author":"Bradford","year":"2015","journal-title":"ASAIO J"},{"key":"10.1111\/jth.14276_bb0150","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/vox.12353","article-title":"Four\u2010factor prothrombin complex concentrates in paediatric patients \u2013 a retrospective case series","volume":"110","author":"Noga","year":"2016","journal-title":"Vox Sang"},{"key":"10.1111\/jth.14276_bb0155","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1056\/NEJMoa1707278","article-title":"Idarucizumab for dabigatran reversal \u2013 full cohort analysis","volume":"377","author":"Pollack","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.14276_bb0160","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s11239-018-1645-y","article-title":"Prothrombin complex concentrate for reversal of direct factor Xa inhibitors prior to emergency surgery or invasive procedure: a retrospective study","volume":"45","author":"Piran","year":"2018","journal-title":"J Thromb Thrombolysis"},{"key":"10.1111\/jth.14276_bb0165","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1161\/CIR.0b013e31823b5fee","article-title":"2011 ACCF\/AHA Guideline for Coronary Artery Bypass Graft Surgery: executive summary: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"124","author":"Hillis","year":"2011","journal-title":"Circulation"},{"key":"10.1111\/jth.14276_bb0170","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1093\/ejcts\/ezu366","volume":"46","author":"Kolh","year":"2014","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1111\/jth.14276_bb0175","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/ejcts\/ezx314","article-title":"2017 EACTS Guidelines on perioperative medication in adult cardiac surgery","volume":"53","author":"Sousa\u2010Uva","year":"2018","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1111\/jth.14276_bb0180","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1161\/CIRCINTERVENTIONS.111.967208","volume":"5","author":"Mahla","year":"2012","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1111\/jth.14276_bb0185","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1016\/j.jtcvs.2014.04.054","article-title":"Should clopidogrel be discontinued before coronary artery bypass grafting for patients with acute coronary syndrome? A systematic review and meta\u2010analysis","volume":"148","author":"Cao","year":"2014","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1111\/jth.14276_bb0190","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1001\/jama.2011.2002","article-title":"Bridging antiplatelet therapy with cangrelor in patients undergoing cardiac surgery: a randomized controlled trial","volume":"307","author":"Angiolillo","year":"2012","journal-title":"JAMA"},{"key":"10.1111\/jth.14276_bb0195","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1161\/01.cir.0000436140.77832.7a","article-title":"Prevention and treatment of thrombosis in pediatric and congenital heart disease: a scientific statement from the American Heart Association","volume":"128","author":"Giglia","year":"2013","journal-title":"Circulation"},{"key":"10.1111\/jth.14276_bb0200","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1213\/ANE.0b013e31827e4e62","article-title":"Review article: heparin sensitivity and resistance: management during cardiopulmonary bypass","volume":"116","author":"Finley","year":"2013","journal-title":"Anest Analg"},{"key":"10.1111\/jth.14276_bb0205","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.bpa.2016.07.002","article-title":"Anticoagulation management during cross\u2010clamping and bypass","volume":"30","author":"Lander","year":"2016","journal-title":"Best Pract Res Clin Anaesthesiol"},{"key":"10.1111\/jth.14276_bb0210","doi-asserted-by":"crossref","first-page":"6667","DOI":"10.1182\/blood-2011-07-364141","article-title":"Mechanism of catheter thrombosis: comparison of the antithrombotic activities of fondaparinux, enoxaparin, and heparin in vitro and in vivo","volume":"118","author":"Yau","year":"2011","journal-title":"Blood"},{"key":"10.1111\/jth.14276_bb0215","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12967-015-0404-5","article-title":"Pharmacokinetic model of unfractionated heparin during and after cardiopulmonary bypass in cardiac surgery","volume":"13","author":"Jia","year":"2015","journal-title":"J Transl Med"},{"key":"10.1111\/jth.14276_bb0220","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.athoracsur.2017.09.061","article-title":"The society of thoracic surgeons, the society of cardiovascular anesthesiologists, and the American Society of Extracorporeal Technology: clinical practice guidelines\u2010anticoagulation during cardiopulmonary bypass","volume":"105","author":"Shore\u2010Lesserson","year":"2018","journal-title":"Ann Thorac Surg"},{"key":"10.1111\/jth.14276_bb0225","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1051\/ject\/201244015","article-title":"Comparison of point\u2010of\u2010care activated clotting time systems utilized in a single pediatric institution","volume":"44","author":"Ojito","year":"2012","journal-title":"J Extra Corpor Technol"},{"key":"10.1111\/jth.14276_bb0230","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1067\/mtc.2002.119060","article-title":"Antithrombin III concentrate to treat heparin resistance in patients undergoing cardiac surgery","volume":"123","author":"Lemmer","year":"2002","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1111\/jth.14276_bb0235","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1213\/00000539-200004000-00008","article-title":"Anticoagulation for cardiac surgery in patients receiving preoperative heparin: use of the high\u2010dose thrombin time","volume":"90","author":"Shore\u2010Lesserson","year":"2000","journal-title":"Anest Analg"},{"key":"10.1111\/jth.14276_bb0240","series-title":"Molecular biology, biochemistry and biophysics","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-642-46294-8_1","article-title":"Protamines","author":"Ando","year":"1973"},{"key":"10.1111\/jth.14276_bb0245","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/S0003-4975(02)04016-X","article-title":"Rapid disappearance of protamine in adults undergoing cardiac operation with cardiopulmonary bypass","volume":"74","author":"Butterworth","year":"2002","journal-title":"Ann Thorac Surg"},{"key":"10.1111\/jth.14276_bb0250","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.bja.2018.01.023","article-title":"Anticoagulant and side\u2010effects of protamine in cardiac surgery: a narrative review","volume":"120","author":"Boer","year":"2018","journal-title":"Br J Anaesth"},{"key":"10.1111\/jth.14276_bb0255","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1213\/00000539-199810000-00008","article-title":"Protamine reversal of heparin affects platelet aggregation and activated clotting time after cardiopulmonary bypass","volume":"87","author":"Mochizuki","year":"1998","journal-title":"Anest Analg"},{"key":"10.1111\/jth.14276_bb0260","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/S0022-5223(19)41499-2","article-title":"Heparin therapy during extracorporeal circulation. I. Problems inherent in existing heparin protocols","volume":"69","author":"Bull","year":"1975","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1111\/jth.14276_bb0265","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/S0003-4975(00)02586-8","article-title":"Individualized heparin and protamine management in infants and children undergoing cardiac operations","volume":"71","author":"Codispoti","year":"2001","journal-title":"Ann Thorac Surg"},{"key":"10.1111\/jth.14276_bb0270","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1213\/01.ane.0000297290.03501.db","article-title":"A comparison of heparin management strategies in infants undergoing cardiopulmonary bypass","volume":"106","author":"Guzzetta","year":"2008","journal-title":"Anest Analg"},{"key":"10.1111\/jth.14276_bb0275","first-page":"II420","article-title":"Heparin binding proteins. Contribution to heparin rebound after cardiopulmonary bypass","volume":"88","author":"Teoh","year":"1993","journal-title":"Circulation"},{"key":"10.1111\/jth.14276_bb0280","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.thromres.2013.12.017","article-title":"Measurement of thrombin generation intra\u2010operatively and its association with bleeding tendency after cardiac surgery","volume":"133","author":"Bosch","year":"2014","journal-title":"Thromb Res"},{"key":"10.1111\/jth.14276_bb0285","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/0003-4975(95)00668-B","article-title":"Heparin causes platelet dysfunction and induces fibrinolysis before cardiopulmonary bypass","volume":"60","author":"Khuri","year":"1995","journal-title":"Ann Thorac Surg"},{"key":"10.1111\/jth.14276_bb0290","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1161\/CIRCULATIONAHA.116.023956","article-title":"Point\u2010of\u2010care hemostatic testing in cardiac surgery: a stepped\u2010wedge clustered randomized controlled trial","volume":"134","author":"Karkouti","year":"2016","journal-title":"Circulation"},{"key":"10.1111\/jth.14276_bb0295","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1056\/NEJMoa1606424","article-title":"Tranexamic acid in patients undergoing coronary\u2010artery surgery","volume":"376","author":"Myles","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.14276_bb0300","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1542\/pir.2017-0032","article-title":"Congenital heart disease","volume":"38","author":"Puri","year":"2017","journal-title":"Pediatr Rev"},{"key":"10.1111\/jth.14276_bb0305","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s12630-015-0500-2","article-title":"Antithrombin activity and heparin response in neonates and infants undergoing congenital cardiac surgery: a retrospective cohort study","volume":"63","author":"Chin","year":"2016","journal-title":"Can J Anaesth"},{"key":"10.1111\/jth.14276_bb0310","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1213\/ANE.0000000000002785","article-title":"Predicting heparin responsiveness in children before cardiopulmonary bypass: a retrospective cohort study","volume":"126","author":"Nakamura","year":"2018","journal-title":"Anest Analg"},{"key":"10.1111\/jth.14276_bb0315","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0022-5223(19)41741-8","article-title":"Heparin rebound. Studies in patients and volunteers","volume":"67","author":"Ellison","year":"1974","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1111\/jth.14276_bb0320","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1093\/ejcts\/ezs455","article-title":"Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio\u2010Thoracic Surgery (EACTS)","volume":"42","author":"Vahanian","year":"2012","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1111\/jth.14276_bb0325","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.healun.2012.09.013","article-title":"The 2013 International Society for Heart and Lung Transplantation Guidelines for mechanical circulatory support: executive summary","volume":"32","author":"Feldman","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"10.1111\/jth.14276_bb0330","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1056\/NEJMoa1300615","article-title":"Dabigatran versus warfarin in patients with mechanical heart valves","volume":"369","author":"Eikelboom","year":"2013","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"10.1111\/jth.14276_bb0335","doi-asserted-by":"crossref","first-page":"S72","DOI":"10.1111\/jth.12961","article-title":"Medical device\u2010induced thrombosis: what causes it and how can we prevent it?","volume":"13","author":"Jaffer","year":"2015","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14276_bb0340","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.athoracsur.2005.07.023","article-title":"Early postoperative anticoagulation after mechanical valve replacement: a systematic review","volume":"81","author":"Kulik","year":"2006","journal-title":"Ann Thorac Surg"},{"key":"10.1111\/jth.14276_bb0345","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1161\/CIRCOUTCOMES.115.002696","article-title":"Safety and use of anticoagulation after aortic valve replacement with bioprostheses: a meta\u2010analysis","volume":"9","author":"Riaz","year":"2016","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1111\/jth.14276_bb0350","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.thromres.2016.11.021","article-title":"Antithrombotic therapy after bioprosthetic aortic valve implantation: Warfarin versus aspirin, a randomized controlled trial","volume":"150","author":"Rafiq","year":"2017","journal-title":"Thromb Res"},{"key":"10.1111\/jth.14276_bb0355","doi-asserted-by":"crossref","first-page":"e123","DOI":"10.1161\/CIR.0000000000000404","volume":"134","author":"Levine","year":"2016","journal-title":"Circulation"},{"key":"10.1111\/jth.14276_bb0360","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/j.amjcard.2013.07.017","article-title":"Meta\u2010analysis of effect of single versus dual antiplatelet therapy on early patency of bypass conduits after coronary artery bypass grafting","volume":"112","author":"Nocerino","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1111\/jth.14276_bb0365","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/jocs.12074","article-title":"Dual anti\u2010platelet therapy after coronary artery bypass grafting: is there any benefit? A systematic review and meta\u2010analysis","volume":"28","author":"Deo","year":"2013","journal-title":"J Card Surg"},{"key":"10.1111\/jth.14276_bb0370","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1111\/jth.12948","article-title":"Antithrombotic therapy for left ventricular assist devices in adults: a systematic review","volume":"13","author":"Baumann Kreuziger","year":"2015","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14276_bb0375","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.athoracsur.2016.07.072","article-title":"Outcomes in HeartMate II patients with no antiplatelet therapy: 2\u2010year results from the European TRACE study","volume":"103","author":"Netuka","year":"2017","journal-title":"Ann Thorac Surg"},{"key":"10.1111\/jth.14276_bb0380","doi-asserted-by":"crossref","first-page":"e003709","DOI":"10.1161\/CIRCHEARTFAILURE.116.003709","article-title":"Increased thromboembolic events with dabigatran compared with vitamin K antagonism in left ventricular assist device patients: a randomized controlled pilot trial","volume":"10","author":"Andreas","year":"2017","journal-title":"Circ Heart Fail"},{"key":"10.1111\/jth.14276_bb0385","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.healun.2010.02.003","article-title":"Post\u2010operative heparin may not be required for transitioning patients with a HeartMate II left ventricular assist system to long\u2010term warfarin therapy","volume":"29","author":"Slaughter","year":"2010","journal-title":"J Heart Lung Transplant"},{"key":"10.1111\/jth.14276_bb0390","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJMoa1313385","article-title":"Unexpected abrupt increase in left ventricular assist device thrombosis","volume":"370","author":"Starling","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.14276_bb0395","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.healun.2016.10.001","article-title":"PREVENtion of HeartMate II pump thrombosis through clinical management: the PREVENT multi\u2010center study","volume":"36","author":"Maltais","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"10.1111\/jth.14276_bb0400","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1053\/j.semperi.2013.11.002","article-title":"Update and outcomes in extracorporeal life support","volume":"38","author":"Paden","year":"2014","journal-title":"Semin Perinatol"},{"key":"10.1111\/jth.14276_bb0405","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1056\/NEJMoa1014164","article-title":"Prospective trial of a pediatric ventricular assist device","volume":"367","author":"Fraser","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.14276_bb0410","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.healun.2017.05.020","article-title":"Impact of a modified anti\u2010thrombotic guideline on stroke in children supported with a pediatric ventricular assist device","volume":"36","author":"Rosenthal","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"10.1111\/jth.14276_bb0415","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1097\/MAT.0000000000000434","article-title":"Antithrombotic therapy in a prospective trial of a pediatric ventricular assist device","volume":"62","author":"Steiner","year":"2016","journal-title":"ASAIO J"},{"key":"10.1111\/jth.14276_bb0420","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1309\/AJCPQ9BYJ0OEENGA","article-title":"Platelet mapping assay interference due to platelet activation in heparinized samples","volume":"142","author":"Nelles","year":"2014","journal-title":"Am J Clin Pathol"},{"key":"10.1111\/jth.14276_bb0425","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1373\/clinchem.2014.226332","article-title":"Precision and reliability of 5 platelet function tests in healthy volunteers and donors on daily antiplatelet agent therapy","volume":"60","author":"Karon","year":"2014","journal-title":"Clin Chem"},{"key":"10.1111\/jth.14276_bb0430","doi-asserted-by":"crossref","first-page":"e001429","DOI":"10.1161\/JAHA.114.001429","article-title":"Neurological complications and outcomes in the Berlin Heart EXCOR(R) pediatric investigational device exemption trial","volume":"4","author":"Jordan","year":"2015","journal-title":"J Am Heart Assoc"},{"key":"10.1111\/jth.14276_bb0435","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.healun.2016.01.019","article-title":"A multicenter study of the HeartWare ventricular assist device in small children","volume":"35","author":"Miera","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"10.1111\/jth.14276_bb0440","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.healun.2016.01.1228","article-title":"Outcomes of pediatric patients supported with continuous\u2010flow ventricular assist devices: a report from the Pediatric Interagency Registry for Mechanical Circulatory Support (PediMACS)","volume":"35","author":"Rossano","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"10.1111\/jth.14276_bb0445","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1053\/j.pcsu.2016.09.003","article-title":"Closing in on the PumpKIN Trial of the Jarvik 2015 Ventricular Assist Device","volume":"20","author":"Baldwin","year":"2017","journal-title":"Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu"},{"key":"10.1111\/jth.14276_bb0450","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1182\/blood-2015-07-660001","article-title":"Reducing the hospital burden of heparin\u2010induced thrombocytopenia: impact of an avoid\u2010heparin program","volume":"127","author":"McGowan","year":"2016","journal-title":"Blood"},{"key":"10.1111\/jth.14276_bb0455","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1055\/s-0037-1602664","article-title":"Heparin\u2010induced thrombocytopenia in cardiac surgery patients","volume":"43","author":"Pishko","year":"2017","journal-title":"Semin Thromb Hemost"},{"key":"10.1111\/jth.14276_bb0460","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/jth.12153","article-title":"Systematic review on heparin\u2010induced thrombocytopenia in children: a call to action","volume":"11","author":"Avila","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14276_bb0465","doi-asserted-by":"crossref","first-page":"e495S","DOI":"10.1378\/chest.11-2303","article-title":"Treatment and prevention of heparin\u2010induced thrombocytopenia: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence\u2010Based Clinical Practice Guidelines","volume":"141","author":"Linkins","year":"2012","journal-title":"Chest"},{"key":"10.1111\/jth.14276_bb0470","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jtcvs.2005.09.057","article-title":"A comparison of bivalirudin to heparin with protamine reversal in patients undergoing cardiac surgery with cardiopulmonary bypass: the EVOLUTION\u2010ON study","volume":"131","author":"Dyke","year":"2006","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1111\/jth.14276_bb0475","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.athoracsur.2006.09.038","article-title":"Bivalirudin during cardiopulmonary bypass in patients with previous or acute heparin\u2010induced thrombocytopenia and heparin antibodies: results of the CHOOSE\u2010ON trial","volume":"83","author":"Koster","year":"2007","journal-title":"Ann Thorac Surg"},{"key":"10.1111\/jth.14276_bb0480","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/ALN.0000000000001976","article-title":"Argatroban and bivalirudin for perioperative anticoagulation in cardiac surgery","volume":"128","author":"Koster","year":"2018","journal-title":"Anesthesiology"},{"key":"10.1111\/jth.14276_bb0485","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1056\/NEJMc1801799","article-title":"Intravenous immune globulin to prevent heparin\u2010induced thrombocytopenia","volume":"378","author":"Warkentin","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.14276_bb0490","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1182\/blood-2014-07-590844","article-title":"Plasma exchange to remove HIT antibodies: dissociation between enzyme\u2010immunoassay and platelet activation test reactivities","volume":"125","author":"Warkentin","year":"2015","journal-title":"Blood"},{"key":"10.1111\/jth.14276_bb0495","first-page":"12","article-title":"Heparin\u2010induced thrombocytopenia in the pediatric population: a review of current literature","volume":"17","author":"Vakil","year":"2012","journal-title":"J Pediatr Pharmacol Ther"},{"key":"10.1111\/jth.14276_bb0500","first-page":"408","article-title":"Bivalirudin as an alternative to heparin for anticoagulation in infants and children","volume":"20","author":"Buck","year":"2015","journal-title":"J Pediatr Pharmacol Ther"},{"key":"10.1111\/jth.14276_bb0505","first-page":"671","article-title":"Pediatric catheterization laboratory anticoagulation with bivalirudin","volume":"77","author":"Forbes","year":"2011","journal-title":"Catheter Cardiovasc Interv"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.14276","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S153878362202918X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S153878362202918X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/jth.14276\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:22:02Z","timestamp":1761535322000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S153878362202918X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":100,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S153878362202918X"],"URL":"https:\/\/doi.org\/10.1111\/jth.14276","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antithrombotic therapy management of adult and pediatric cardiac surgery patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/jth.14276","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2018 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}